Sung‐Soo Yoon

1995–2025 年に発表

別表記
Sung-Soo Yoon · Sung Soo Yoon
126
論文数
19,896
被引用数
56
h 指数
112
i10 指数

被引用数

Sung‐Soo Yoon の年別被引用数1948 年: 被引用 1 件1988 年: 被引用 3 件1995 年: 被引用 5 件1996 年: 被引用 3 件1997 年: 被引用 4 件1998 年: 被引用 3 件1999 年: 被引用 2 件2000 年: 被引用 3 件2001 年: 被引用 7 件2002 年: 被引用 4 件2003 年: 被引用 13 件2004 年: 被引用 12 件2005 年: 被引用 10 件2006 年: 被引用 8 件2007 年: 被引用 6 件2008 年: 被引用 8 件2009 年: 被引用 4 件2010 年: 被引用 7 件2011 年: 被引用 11 件2012 年: 被引用 16 件2013 年: 被引用 16 件2014 年: 被引用 57 件2015 年: 被引用 80 件2016 年: 被引用 122 件2017 年: 被引用 146 件2018 年: 被引用 144 件2019 年: 被引用 535 件2020 年: 被引用 941 件2021 年: 被引用 1,183 件2022 年: 被引用 1,014 件2023 年: 被引用 818 件2024 年: 被引用 1,318 件2025 年: 被引用 645 件2026 年: 被引用 8 件1949〜1987 年は被引用が無いため表示していません1989〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,034 件、この内訳の 24.7%中国: 引用元論文 869 件、この内訳の 7.1%イギリス: 引用元論文 835 件、この内訳の 6.8%ドイツ: 引用元論文 781 件、この内訳の 6.4%イタリア: 引用元論文 702 件、この内訳の 5.7%フランス: 引用元論文 615 件、この内訳の 5%スペイン: 引用元論文 496 件、この内訳の 4%日本: 引用元論文 496 件、この内訳の 4%カナダ: 引用元論文 404 件、この内訳の 3.3%オーストラリア: 引用元論文 370 件、この内訳の 3%オランダ: 引用元論文 331 件、この内訳の 2.7%韓国: 引用元論文 255 件、この内訳の 2.1%
0%24.7%その他 25.2%

分野

  • Medicine63.1%
  • Biochemistry, Genetics and Molecular Biology25%
  • Immunology and Microbiology7.9%
  • Materials Science0.9%
  • Engineering0.7%
  • Agricultural and Biological Sciences0.5%
  • その他1.9%

トピック

  • Acute Myeloid Leukemia Research9.7%
  • Multiple Myeloma Research and Treatments6.3%
  • Protein Degradation and Inhibitors4.4%
  • Cancer Genomics and Diagnostics3.2%
  • CAR-T cell therapy research3.1%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.1%
  • その他70.2%

共著者

全論文

検索で開く
  1. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 2,771

  2. Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark J. Levis - New England Journal of Medicine 2019 被引用: 1,239

  3. Patterns of somatic structural variation in human cancer genomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. Lynn Fink, Milana Frenkel‐Morgenstern, Dale W. Garsed, Mark Gerstein, Dmitry A. Gordenin, David Haan, James E. Haber, Julian M. Hess, Barbara Hutter, Marcin Imieliński, David T. W. Jones, Young Seok Ju, Marat D. Kazanov, Leszek J. Klimczak, Youngil Koh, Jan O. Korbel, Kiran Kumar, Eunjung Alice Lee, Jake June-Koo Lee, Yilong Li, Andy G. Lynch, Geoff Macintyre, Florian Markowetz, Iñigo Martincorena, Alexander Martinez-Fundichely, Matthew Meyerson, Satoru Miyano, Hidewaki Nakagawa, Fábio C. P. Navarro, Stephan Ossowski, Peter J. Park, John V. Pearson, Montserrat Puiggròs, Karsten Rippe, Nicola D. Roberts, Steven A. Roberts, Bernardo Rodriguez-Martin, Steven E. Schumacher, Ralph Scully, Mark Shackleton, Nikos Sidiropoulos, Lina Sieverling, Chip Stewart, David Torrents, José M. C. Tubío, Izar Villasante, Nicola Waddell, Jeremiah A. Wala, Joachim Weischenfeldt, Lixing Yang, Xiaotong Yao, Sung-Soo Yoon, Jorge Zamora, Cheng-Zhong Zhang, Joachim Weischenfeldt, Rameen Beroukhim, Peter J. Campbell, Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams, Nishant Agrawal, Keun Soo Ahn, Sung‐Min Ahn, Hiroshi Aikata, Rehan Akbani, Kadir C. Akdemir, Hikmat Al‐Ahmadie, Sultan T. Al‐Sedairy ほか 1,311 名 - Nature 2020 被引用: 998

  4. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Milana Frenkel-Morgenstern, Dale W. Garsed, Mark Gerstein, Dmitry A. Gordenin, David Haan, James E. Haber, Julian M. Hess, Barbara Hutter, Marcin Imieliński, David Jones, Young Seok Ju, Marat D. Kazanov, Leszek J. Klimczak, Youngil Koh, Jan O. Korbel, Kiran Kumar, Eunjung Alice Lee, Jake June-Koo Lee, Yilong Li, Andy G. Lynch, Geoff Macintyre, Florian Markowetz, Iñigo Martincorena, Alexander Martinez‐Fundichely, Satoru Miyano, Hidewaki Nakagawa, Fabio C. P. Navarro, Stephan Ossowski, Peter J. Park, John V. Pearson, Montserrat Puiggròs, Karsten Rippe, Nicola D. Roberts, Steven A. Roberts, Bernardo Rodriguez-Martin, Steven E. Schumacher, Ralph Scully, Mark Shackleton, Nikos Sidiropoulos, Lina Sieverling, Chip Stewart, David Torrents, José M. C. Tubío, Izar Villasante, Nicola Waddell, Jeremiah A. Wala, Joachim Weischenfeldt, Lixing Yang, Xiaotong Yao, Sung-Soo Yoon, Jorge Zamora, Cheng-Zhong Zhang, Peter J. Park, Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams, Nishant Agrawal, Keun Soo Ahn, Sung‐Min Ahn, Hiroshi Aikata, Rehan Akbani, Kadir C. Akdemir, Hikmat Al‐Ahmadie, Sultan T. Al‐Sedairy, Fátima Al‐Shahrour, Malik Alawi, Monique Albert, Kenneth Aldape ほか 1,307 名 - Nature Genetics 2020 被引用: 774

  5. Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 290

  6. Comprehensive molecular characterization of mitochondrial genomes in human cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fátima Al‐Shahrour, Malik Alawi, Monique Albert, Kenneth Aldape, Ludmil B. Alexandrov, Adrian Ally, Kathryn Alsop, Eva G. Álvarez, Fernanda Amary, Samirkumar B. Amin, Brice Aminou, Ole Ammerpohl, Matthew J. Anderson, Yeng Ang, Davide Antonello, Pavana Anur, Samuel Aparício, Elizabeth L. Appelbaum, Yasuhito Arai, Axel Aretz, Koji Arihiro, Shun‐ichi Ariizumi, Joshua Armenia, Laurent Arnould, L. Sylvia, Yassen Assenov, Gurnit Atwal, Sietse Aukema, J. Todd Auman, Miriam R. R. Aure, Philip Awadalla, Marta Aymerich, Gary D. Bader, Adrian Baez‐Ortega, Matthew H. Bailey, Peter J. Bailey, Miruna Balasundaram, Saianand Balu, Pratiti Bandopadhayay, Rosamonde E. Banks, Stefano Barbi, Andrew P. Barbour, Jonathan Barenboim, Jill S. Barnholtz‐Sloan, Hugh Barr, Elisabet Barrera, John Bartlett, Javier Bartolomé, Claudio Bassi, Oliver F. Bathe, Daniel Baumhoer, Prashant Bavi, Stephen B. Baylin, Wojciech Bażant, Duncan Beardsmore, Timothy A. Beck, Sam Behjati, Andreas Behren, Beifang Niu, Cindy Bell, Sergi Beltrán, Christopher C. Benz, Andrew Berchuck, Anke Bergmann, Erik N. Bergstrom, Benjamin P. Berman, Daniel M. Berney, Stephan H. Bernhart, Rameen Beroukhim, Mario Berríos ほか 1,241 名 - Nature Genetics 2020 被引用: 515

  7. Clinical and biological implications of driver mutations in myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellström‐Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter J. Campbell - Blood 2013 被引用: 1,832

  8. Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Hematology 2024 被引用: 202

  9. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Angona, Rosa Ayala, Soo‐Mee Bang, Bruce Bank, Fiorenza Barraco, Eloise Beggiato, Fleur Samantha Benghiat, Massimiliano Bonifacio, Claire Bories, Gabriela Borsaru, Mette Brabrand, Andrei Braester, Andes Broliden, Veronika Buxhofer‐Ausch, Nathalie Cambier, Marianna Caramella, Benjamin Carpentier, Nicola Cascavilla, Maria Giraldo Castellano, Hung Chang, Chih‐Cheng Chen, June‐Won Cheong, Yunsuk Choi, Philip Choi, Maria Teresa Corsetti, Isabel Montero Cuadrado, Julia Cunningham, Gandhi Damaj, Valerio De Stefano, Robert Delage, Regina Garcĺa Delgado, José Miguel Torregrosa Diaz, Péter Dombi, Viviane Dubruille, Miklós Egyed, Daniel El Fassi, Anna Elinder-Camburn, Elena Maria Elli, Martin Ellis, Carmen Fava, Salman Fazal, Angela Fleischman, Lynda Foltz, María Laura Fox, Nashat Gabrail, Jose Valentĺn Garcĺa-Gutiérrez, Aaron T. Gerds, Stéphane Girault, Heinz Gisslinger, Alexandru Gluvacov, Yeow Tee Goh, Joachim R. Göthert, Nikki Granacher, Sebastian Grosicki, Vikas Gupta, Evgeni Hadjiev, Kaoutar Hafraoui, Aryan Hamed, Claire Harrison, Hans Carl Hasselbalch, Hanns Hauser, Mark Heaney, Holger Hebart, Jesús María Hernández‐Rivas, Victor Higuero Saavedra, Christopher Hillis, Hsin‐An Hou, Jonathan P. How, Daniel Huang, Marek Hus ほか 95 名 - The Lancet 2023 被引用: 185

  10. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 984

  11. Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 1,434

  12. First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 87

  13. Integrated molecular analysis of adult T cell leukemia/lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hideaki Ogasawara, Toshitaka Sato, Ken Sasai, Kenzo Muramoto, Marina Penova, Takahisa Kawaguchi, Hiromi Nakamura, Natsuko Hama, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Takuro Kameda, Tsuyoshi Nakamaki, Ken Ishiyama, Shuichi Miyawaki, Sung‐Soo Yoon, Kensei Tobinai, Yasushi Miyazaki, Akifumi Takaori‐Kondo, Fumihiko Matsuda, Kengo Takeuchi, Osamu Nureki, Hiroyuki Aburatani, Toshiki Watanabe, Tatsuhiro Shibata, Masao Matsuoka, Satoru Miyano, Kazuya Shimoda, Seishi Ogawa - Nature Genetics 2015 被引用: 844

  14. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 被引用: 438

  15. Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2023 被引用: 93

  16. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , I−Ru Chen, Susan S. Huang, Jin Seok Kim, Gaetano La Manna, Giorgia Comai, Maria Cappuccilli, Moglie Le Quintrec, Guillaume Jeantet, Iino Fumie, Yosu Luque, Jan Menne, J Morelle, Éric Goffin, Anja Mühlfeld, Shashi Nagaraj, Gowthami M. Arepally, Doyeun Oh, Masayoshi Okumi, Manuel Praga Terente, Elena Gutiérrez, Paola Rodrı́guez, François Provôt, Ulf Schönermarck, Michael Fischereder, Natàlia Ramos Terrada, Barbara Seitz‐Polski, Guillaume Favrè, Sonia Boyer‐Suavet, Maria Vinogradova, Tatiana Kirsanova, Edwin Wong - Kidney International 2020 被引用: 219

  17. RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Moore, Meike Schneider, Wolfgang Jacob, Maja Weisser, Martin Hutchings, Caroline Hasselbalch Riley - Blood 2022 被引用: 90

  18. Surface Charge-Switching Polymeric Nanoparticles for Bacterial Cell Wall-Targeted Delivery of Antibiotics

    著者: , , , , , - ACS Nano 2012 被引用: 534

  19. Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

    著者: , , , , , , , , , , , , , , , , , , , , - Blood 2022 被引用: 137

  20. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Javier de la Rubia, Peter Gimsing, Sagar Lonial, Jonathan L. Kaufman, Enrique M. Ocio, Ljupco Veskovski, Sang Kyun Sohn, Ming-Chung Wang, Jae Hoon Lee, Hermann Einsele, Monika Sopala, Claudia Corrado, B. Bengoudifa, Florence Binlich, Paul G. Richardson - The Lancet Oncology 2014 被引用: 788

  21. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dale W. Garsed, Mark Gerstein, Dmitry A. Gordenin, David Haan, James E. Haber, Julian M. Hess, Barbara Hutter, Marcin Imieliński, David Jones, Young Seok Ju, Marat D. Kazanov, Leszek J. Klimczak, Youngil Koh, Jan O. Korbel, Kiran Kumar, Eunjung Alice Lee, Jake June-Koo Lee, Yilong Li, Andy G. Lynch, Geoff Macintyre, Florian Markowetz, Iñigo Martincorena, Alexander Martinez‐Fundichely, Matthew Meyerson, Satoru Miyano, Hidewaki Nakagawa, Fábio C. P. Navarro, Stephan Ossowski, Peter J. Park, John V. Pearson, Montserrat Puiggròs, Karsten Rippe, Nicola D. Roberts, Steven A. Roberts, Bernardo Rodriguez-Martin, Steven E. Schumacher, Ralph Scully, Mark Shackleton, Nikos Sidiropoulos, Lina Sieverling, Chip Stewart, David Torrents, José M. C. Tubío, Izar Villasante, Nicola Waddell, Jeremiah A. Wala, Joachim Weischenfeldt, Lixing Yang, Xiaotong Yao, Sung-Soo Yoon, Jorge Zamora, Cheng‐Zhong Zhang, Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams, Nishant Agrawal, Keun Soo Ahn, Sung‐Min Ahn, Hiroshi Aikata, Rehan Akbani, Kadir C. Akdemir, Hikmat Al‐Ahmadie, Sultan T. Al‐Sedairy, Fátima Al‐Shahrour, Malik Alawi, Monique Albert, Kenneth Aldape, Ludmil B. Alexandrov ほか 1,306 名 - Nature Genetics 2020 被引用: 308

  22. Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 128

  23. Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2025 被引用: 88

  24. The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 被引用: 130